Skip to Content

HepaGam B Approval History

  • FDA approved: Yes (First approved January 30th, 2006)
  • Brand name: HepaGam B
  • Generic name: hepatitis B immune globulin
  • Company: Cangene
  • Treatment for: Exposure to Hepatitis B Virus

HepaGam B is hepatitis B immune globulin (human), a purified antibody or hyperimmune that is specific for the hepatitis B virus. HepaGam B is indicated for treatment following acute exposure to hepatitis B virus.

Development History and FDA Approval Process for HepaGam B

Jan 30, 2006Approval HepaGam B - Cangene - Treatment for Exposure to Hepatitis B

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.